Colombia’s New Pricing Decree Could Impact Drug Registration, Warns Industry Group

28 Mar 2018

• By Francesca Bruce

The pharmaceutical industry in Colombia is concerned that a new pricing decree could impact the regulatory process for new drugs.

Colombia — Colombia's Pharmaceutical Industry Association Calls For Pricing Decree to be Revised

More from Government Payers

More from Market Access